C.E. Gomez

Type de document

Articles (8)

Co-auteur

Date

Source

Mot-clé

vecteur (8) Cells (8) Expression (7) virus (6) protéine (6) gène (6) Vaccinia (6) Deletion (5) Genes (5) Mice (5) Memory (5) Antigens (5) ADN (4) Dendritic cells (4) Macrophages (4) Immune response (4) DNA (4) immunité (3) analyse (3) Phenotype (3) Viruses (3) Vaccines (3) T cells (3) Human beings (3) Interferon (3) Immunoglobulins (3) Immunity (3) Cytokines (3) Receptors (3) Viruses (3)

Documents écrit par C.E. Gomez (8) | parle de C.E. Gomez (0)

Interleukin-1- and type I interferon-dependent enhanced immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef vaccine vector with dual deletions of type I and type II interferon-binding proteins.
J. Delaloye et al. (2015)
Deletion of the Vaccinia Virus Gene A46R, Encoding for an Inhibitor of TLR Signalling, Is an Effective Approach to Enhance the Immunogenicity in Mice of the HIV/AIDS Vaccine Candidate NYVAC-C.
B. Perdiguero et al. (2013)
Systems analysis of MVA-C induced immune response reveals its significance as a vaccine candidate against HIV/AIDS of clade C.
C.E. Gómez et al. (2012)
Deletion of the viral anti-apoptotic gene F1L in the HIV/AIDS vaccine candidate MVA-C enhances immune responses against HIV-1 antigens.
B. Perdiguero et al. (2012)
Improved Innate and Adaptive Immunostimulation by Genetically Modified HIV-1 Protein Expressing NYVAC Vectors.
E.D. Quakkelaar et al. (2011)
A Candidate HIV/AIDS Vaccine (MVA-B) Lacking Vaccinia Virus Gene C6L Enhances Memory HIV-1-Specific T-Cell Responses.
J. García-Arriaza et al. (2011)
Improved NYVAC-based vaccine vectors.
K.V. Kibler et al. (2011)
Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome.
J. Delaloye et al. (2009)